Wolverine Asset Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,187
| Closed | -$51K | – | 2406 |
|
|
2022
Q1 | $51K | Sell |
5,187
-45,165
| -90% | -$444K | ﹤0.01% | 1275 |
|
|
2021
Q4 | $491K | Sell |
50,352
-7,004
| -12% | -$68.3K | ﹤0.01% | 787 |
|
|
2021
Q3 | $560K | Sell |
57,356
-5,170
| -8% | -$50.5K | ﹤0.01% | 711 |
|
|
2021
Q2 | $615K | Buy |
62,526
+5,298
| +9% | +$52.1K | ﹤0.01% | 658 |
|
|
2021
Q1 | $571K | Buy |
57,228
+54,228
| +1,808% | +$541K | ﹤0.01% | 699 |
|
|
2020
Q4 | $30K | Buy |
+3,000
| New | +$30K | ﹤0.01% | 1106 |
|